SG Americas Securities
STOK icon

SG Americas Securities’s Stoke Therapeutics STOK Stock Holding History

SG Americas Securities’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.11M Buy
33,996
+8,160
+32% +$268K ﹤0.01% 1706
2025
Q4 		$820K Buy
25,836
+16,840
+187% +$506K ﹤0.01% 2168
2025
Q3 		$211K Buy
+8,996
New +$154K ﹤0.01% 2722
2025
Q1 		– Sell
-10,768
Closed -$119K – 3753
2024
Q4 		$119K Sell
10,768
-4,149
-28% -$51K ﹤0.01% 2605
2024
Q3 		$183K Sell
14,917
-53,684
-78% -$760K ﹤0.01% 2576
2024
Q2 		$927K Buy
68,601
+58,943
+610% +$796K 0.01% 1338
2024
Q1 		$130K Sell
9,658
-5,443
-36% -$33K ﹤0.01% 2337
2023
Q4 		$79K Buy
15,101
+1,544
+11% +$6.6K ﹤0.01% 2834
2023
Q3 		$53K Buy
+13,557
New +$89.1K ﹤0.01% 2928
2022
Q4 		– Sell
-7,933
Closed -$102K – 3361
2022
Q3 		$102K Buy
+7,933
New +$126K ﹤0.01% 2852
2022
Q2 		– Sell
-182,591
Closed -$3.84M – 3602
2022
Q1 		$3.84M Buy
182,591
+152,149
+500% +$3.05M 0.03% 547
2021
Q4 		$730K Sell
30,442
-11,372
-27% -$271K ﹤0.01% 1876
2021
Q3 		$1.06M Buy
41,814
+24,697
+144% +$689K 0.01% 1861
2021
Q2 		$576K Buy
17,117
+2,649
+18% +$93.6K ﹤0.01% 1878
2021
Q1 		$562K Buy
+14,468
New +$824K ﹤0.01% 1944
2020
Q4 		– Sell
-25,526
Closed -$855K – 3467
2020
Q3 		$855K Buy
25,526
+246
+1% +$7.02K 0.01% 1278
2020
Q2 		$602K Buy
25,280
+18,497
+273% +$439K 0.01% 1912
2020
Q1 		$155K Buy
6,783
+2,691
+66% +$66.5K ﹤0.01% 2694
2019
Q4 		$116K Buy
+4,092
New +$103K ﹤0.01% 2866
2019
Q3 		– Sell
-13,400
Closed -$391K – 3198
2019
Q2 		$391K Buy
+13,400
New +$360K ﹤0.01% 2035

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

SG Americas Securities's STOK Position: Q1 2026 in Review

SG Americas Securities increased its Stoke Therapeutics (STOK) stake by 32% in Q1 2026, buying an estimated $268K and bringing the position to 33,996 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1706.

SG Americas Securities first reported a position in STOK in Q2 2019 and has held it in 20 quarters since. The position peaked at $3.84M in Q1 2022. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • SG Americas Securities held 33,996 shares of Stoke Therapeutics worth $1.11M as of Q1 2026.
  • SG Americas Securities bought 8,160 Stoke Therapeutics shares in Q1 2026, an estimated $268K.
  • Stoke Therapeutics made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #1706 holding.
  • SG Americas Securities first reported a position in Stoke Therapeutics in Q2 2019 and has held it in 20 quarters since.
  • SG Americas Securities's Stoke Therapeutics position peaked at $3.84M in Q1 2022.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.